-
1
-
-
19944401083
-
-
Garaj V., Puccetti L., Fasolis G., Winum J.Y., Montero J.L., Scozzafava A., Vullo D., Innocenti A., and Supuran C.T. Bioorg. Med. Chem. Lett. 15 (2005) 3102-3108
-
(2005)
Bioorg. Med. Chem. Lett.
, vol.15
, pp. 3102-3108
-
-
Garaj, V.1
Puccetti, L.2
Fasolis, G.3
Winum, J.Y.4
Montero, J.L.5
Scozzafava, A.6
Vullo, D.7
Innocenti, A.8
Supuran, C.T.9
-
4
-
-
0029862077
-
-
Whitten J.P., Xie Y.F., Erickson P.E., Webb T.R., De Souza E.B., Grigoriadis D.E., and McCarthy J.R. J. Med. Chem. 39 (1996) 4354-4357
-
(1996)
J. Med. Chem.
, vol.39
, pp. 4354-4357
-
-
Whitten, J.P.1
Xie, Y.F.2
Erickson, P.E.3
Webb, T.R.4
De Souza, E.B.5
Grigoriadis, D.E.6
McCarthy, J.R.7
-
5
-
-
0026346838
-
-
Hasegawa Y., Yanagisawa T., Okui Y., Sato T., Hosaka K., Chin M., and Mitsuhashi H. Chem. Pharm. Bull. 39 (1991) 3180-3182
-
(1991)
Chem. Pharm. Bull.
, vol.39
, pp. 3180-3182
-
-
Hasegawa, Y.1
Yanagisawa, T.2
Okui, Y.3
Sato, T.4
Hosaka, K.5
Chin, M.6
Mitsuhashi, H.7
-
6
-
-
18444369935
-
-
Pitts W.J., Guo J., Dhar T.G.M., Shen Z., Gu H., Watterson S.H., Bednarz M.S., Chen B.C., Barrish J.C., Bassolino D., Cheney D., Fleener C.A., Rouleau K.A., Hollenbaugh D.L., and Iwanowicz E.J. Bioorg. Med. Chem. Lett. 12 (2002) 2137-2140
-
(2002)
Bioorg. Med. Chem. Lett.
, vol.12
, pp. 2137-2140
-
-
Pitts, W.J.1
Guo, J.2
Dhar, T.G.M.3
Shen, Z.4
Gu, H.5
Watterson, S.H.6
Bednarz, M.S.7
Chen, B.C.8
Barrish, J.C.9
Bassolino, D.10
Cheney, D.11
Fleener, C.A.12
Rouleau, K.A.13
Hollenbaugh, D.L.14
Iwanowicz, E.J.15
-
7
-
-
0033598415
-
-
Hajduk P.J., Dinges J., Schkeryantz J.M., Janowick D., Kaminski M., Tufano M., Augeri D.J., Petros A., Nienaber V., Zhong P., Hammond R., Coen M., Beutel B., Katz L., and Fesik S.W. J. Med. Chem. 42 (1999) 3852-3859
-
(1999)
J. Med. Chem.
, vol.42
, pp. 3852-3859
-
-
Hajduk, P.J.1
Dinges, J.2
Schkeryantz, J.M.3
Janowick, D.4
Kaminski, M.5
Tufano, M.6
Augeri, D.J.7
Petros, A.8
Nienaber, V.9
Zhong, P.10
Hammond, R.11
Coen, M.12
Beutel, B.13
Katz, L.14
Fesik, S.W.15
-
8
-
-
0014880025
-
-
Irikura T., Abe Y., Okamura K., Higo K., Maeda A., Morinaga F., Shirai G., and Hatae S. J. Med. Chem. 13 (1970) 1081-1089
-
(1970)
J. Med. Chem.
, vol.13
, pp. 1081-1089
-
-
Irikura, T.1
Abe, Y.2
Okamura, K.3
Higo, K.4
Maeda, A.5
Morinaga, F.6
Shirai, G.7
Hatae, S.8
-
15
-
-
65649088726
-
-
Kaila J.C., Baraiya A.B., Pandya A.N., Jalani H.B., Vasu K.K., and Sudarsanam V. Tetrahedron Lett. 50 (2009) 3955-3958
-
(2009)
Tetrahedron Lett.
, vol.50
, pp. 3955-3958
-
-
Kaila, J.C.1
Baraiya, A.B.2
Pandya, A.N.3
Jalani, H.B.4
Vasu, K.K.5
Sudarsanam, V.6
-
20
-
-
75949116081
-
-
note
-
General experimental procedure for the preparation of trisubstituted 1,3,5-triazines: To a stirred solution of isothiocyanate 1 (1 mmol) in THF (5 mL), N,N-diethylamidine 2 (1 mmol) was added at room temperature and allowed to stir for 2 h. To the stirred reaction mixture triethylamine (15 mmol) and carbamidine hydrochloride 4 (1.2 mmol) were added at room temperature. Mercury(II) chloride (1 mmol) was added slowly to the reaction mixture (slight exothermic) and the mixture was allowed to stir for another 4 h at room temperature. Initiation of the desulfurization was observed by the formation of black HgS precipitate. Progress of the reaction was monitored by TLC using ethyl acetate/hexane (3:7) as a mobile phase. After the completion of the reaction, the reaction mixture was diluted with THF (5 mL) and filtered through a Celite bed to remove the black precipitate of HgS. The filtrate was concentrated in vacuum and purified by silica gel (60-120 mesh) column chromatography using 12% ethyl acetate in hexane as a mobile phase to give triazines 5. The same experimental protocol was followed for the preparation of 2,5-diamino-1,3,5-triazines (Scheme 2, Table 1, entries 10-13) using tetramethylguanidine instead of N,N-diethylamidines.
-
-
-
|